The announcement comes during the 2021 United Nations Climate Change Conference (COP 26), where world leaders are focusing on collectively cutting greenhouse gas (GHG) emissions and limiting global warming to 1.5 degrees Celsius compared to pre-industrial levels.
As published in Medtronic's new Decarbonization Roadmap, the FY45 milestone builds on the company's existing goal of reaching carbon neutrality in its operations by FY30, to encompass GHG emissions reductions across its entire value chain. To achieve its ambition, Medtronic will pursue setting GHG emission reduction targets across scopes 1, 2, and 3 through the Science-Based Targets Initiative (SBTi) – a multi-year initiative that provides companies a clearly defined path to reduce emissions aligned with the Paris Agreement.
Read the full release here.
Get the latest insights, trends, and innovations to help position yourself at the forefront of sustainable business leadership—delivered straight to your inbox.
Medtronic
Published Nov 8, 2021 12pm EST / 9am PST / 5pm GMT / 6pm CET